The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

Disrupted sleep patterns in Alzheimer’s disease may be more than a symptom—they could be a driving force. Researchers at Washington University found that the brain’s circadian rhythms are thrown off ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

In this context, researchers have connected neurotoxins from algal blooms to brain changes associated with an ...

Hundreds of participants gathered at Earl Brown Park in DeLand on a cooler Saturday morning for a walk to raise funds and ...

This is the third walk back since Hurricane Michael. All of the events in the area this weekend raised more than $75,000 for ...

Landmarks across Syracuse, including 191 Peachtree Tower and 1180 Peachtree, together with more than 1,500 buildings and ...

The community walks with Alzheimer's Association to raise funds that will go towards advancement for research in a cure.

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease ...

In recognition of Alzheimer’s Awareness Month, the Centers for Medicare and Medicaid Services should review and revise policies for Alzheimer’s disease therapies to clear the path for early ...